Filing Details
- Accession Number:
- 0001645627-18-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-31 14:13:10
- Reporting Period:
- 2018-12-24
- Accepted Time:
- 2018-12-31 14:13:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,590,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,592,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,593,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,595,097 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 100 | $0.02 | 26,595,197 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,597,197 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,599,197 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 100 | $0.02 | 26,599,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,600,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 2,000 | $0.02 | 26,602,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-24 | 1,000 | $0.02 | 26,603,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,604,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,605,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,606,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,607,297 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 100 | $0.02 | 26,607,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,608,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 2,000 | $0.02 | 26,610,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 200 | $0.02 | 26,610,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 3,000 | $0.02 | 26,613,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,614,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,615,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,616,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,617,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,618,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-26 | 1,000 | $0.02 | 26,619,597 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
